Cancer therapy by cyclin-dependent kinase inhibitors (CDKIs)
A major characteristic of cancer is dysregulated cell division, which results in aberrant growth of cells. Consequently, medicinal targets that prevent cell division would be useful in the fight against cancer. The primary regulator of proliferation is a complex consisting of cyclin and cyclin-depen...
| Príomhchruthaitheoirí: | , , , , , |
|---|---|
| Formáid: | Alt |
| Teanga: | English |
| Foilsithe / Cruthaithe: |
IfADo - Leibniz Research Centre for Working Environment and Human Factors, Dortmund
2024-06-01
|
| Sraith: | EXCLI Journal : Experimental and Clinical Sciences |
| Ábhair: | |
| Rochtain ar líne: | https://www.excli.de/excli/article/view/7076 |